298 related articles for article (PubMed ID: 1982914)
1. The current status of gastric prokinetic drugs.
Schapira M; Henrion J; Heller FR
Acta Gastroenterol Belg; 1990; 53(4):446-57. PubMed ID: 1982914
[TBL] [Abstract][Full Text] [Related]
2. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
McCallum RW
Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
[TBL] [Abstract][Full Text] [Related]
3. Review article: promotility drugs in the treatment of gastro-oesophageal reflux disease.
Ramirez B; Richter JE
Aliment Pharmacol Ther; 1993 Feb; 7(1):5-20. PubMed ID: 8094981
[TBL] [Abstract][Full Text] [Related]
4. [Prokinetic drugs in digestive disorders].
Carella G; Marra L
Clin Ter; 1993 Sep; 143(3):219-24. PubMed ID: 8222553
[TBL] [Abstract][Full Text] [Related]
5. Prokinetic therapy for gastroesophageal reflux disease.
Robinson M
Am Fam Physician; 1995 Sep; 52(3):957-62, 965-6. PubMed ID: 7653432
[TBL] [Abstract][Full Text] [Related]
6. Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis.
Brown CK; Khanderia U
Clin Pharm; 1990 May; 9(5):357-65. PubMed ID: 2190745
[TBL] [Abstract][Full Text] [Related]
7. Use of prokinetic agents in special populations.
Horn JR
Am J Health Syst Pharm; 1996 Nov; 53(22 Suppl 3):S27-9. PubMed ID: 8931828
[TBL] [Abstract][Full Text] [Related]
8. [Prokinetic drugs].
Hellström P
Nord Med; 1992; 107(11):274-7. PubMed ID: 1448341
[TBL] [Abstract][Full Text] [Related]
9. Prokinetic agents: a key in the future of gastroenterology.
Reynolds JC
Gastroenterol Clin North Am; 1989 Jun; 18(2):437-57. PubMed ID: 2668178
[TBL] [Abstract][Full Text] [Related]
10. Review of the current status of prokinetic agents in gastroenterology.
McCallum RW
Am J Gastroenterol; 1985 Dec; 80(12):1008-16. PubMed ID: 4072997
[No Abstract] [Full Text] [Related]
11. [Drug therapy of gastrointestinal motility disorders].
Jia B
Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):151-2. PubMed ID: 7648932
[No Abstract] [Full Text] [Related]
12. Drug therapy of reflux oesophagitis: an update.
Tytgat GN
Scand J Gastroenterol Suppl; 1989; 168():38-49. PubMed ID: 2575792
[TBL] [Abstract][Full Text] [Related]
13. Prokinetic agents in postgastrectomy patients.
Patterson DJ
Gastroenterol Clin North Am; 1994 Jun; 23(2):313-25. PubMed ID: 7915253
[TBL] [Abstract][Full Text] [Related]
14. [Prokinetics in reflux disease. Action mechanisms and clinical effects].
Hatlebakk JG; Berstad A
Tidsskr Nor Laegeforen; 1994 Feb; 114(6):689-92. PubMed ID: 8191452
[TBL] [Abstract][Full Text] [Related]
15. [Pharmacologic and clinical differentiation of prokinetic drugs].
May B; Greving I
Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
[TBL] [Abstract][Full Text] [Related]
16. General pharmacology of the four gastrointestinal motility stimulants bethanechol, metoclopramide, trimebutine, and cisapride.
Megens AA; Awouters FH; Niemegeers CJ
Arzneimittelforschung; 1991 Jun; 41(6):631-4. PubMed ID: 1930352
[TBL] [Abstract][Full Text] [Related]
17. Prokinetic therapy in gastroesophageal reflux disease.
Champion MC
Can J Gastroenterol; 1997 Sep; 11 Suppl B():55B-65B. PubMed ID: 9347180
[TBL] [Abstract][Full Text] [Related]
18. Domperidone: a peripherally acting dopamine2-receptor antagonist.
Barone JA
Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
[TBL] [Abstract][Full Text] [Related]
19. Prokinetic agents.
Reynolds JC; Putnam PE
Gastroenterol Clin North Am; 1992 Sep; 21(3):567-96. PubMed ID: 1516959
[TBL] [Abstract][Full Text] [Related]
20. Control of gastroduodenal coordination: dopaminergic and cholinergic pathways.
Schuurkes JA; Van Nueten JM
Scand J Gastroenterol Suppl; 1984; 92():8-12. PubMed ID: 6146199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
